Susan L. Cohn to Gangliosides
This is a "connection" page, showing publications Susan L. Cohn has written about Gangliosides.
Connection Strength
0.238
-
Comparative pharmacokinetics, safety, and tolerability of two sources of ch14.18 in pediatric patients with high-risk neuroblastoma following myeloablative therapy. Cancer Chemother Pharmacol. 2016 Feb; 77(2):405-12.
Score: 0.141
-
Anti-GD2 antibody with GM-CSF, interleukin-2, and isotretinoin for neuroblastoma. N Engl J Med. 2010 Sep 30; 363(14):1324-34.
Score: 0.097